Ipsos: acquires Shanghai Focus RX Research
(CercleFinance.com) - Ipsos has announced the acquisition of Shanghai Focus RX Research, in a deal that will significantly strengthen its pharmaceutical research expertise in China and create a favorable environment for its healthcare business.
Shanghai Focus RX Research specializes in RX market research (prescription drugs), including studies on regulatory and environmental constraints, pharmaceutical market development and product strategies.
The company has gained the loyalty of some of the largest multinationals in the pharmaceutical field. Its 22 specialists will join the Ipsos Healthcare Insights team and Frank Ma, CEO and founder of Focus RX Research, will lead the new team.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Shanghai Focus RX Research specializes in RX market research (prescription drugs), including studies on regulatory and environmental constraints, pharmaceutical market development and product strategies.
The company has gained the loyalty of some of the largest multinationals in the pharmaceutical field. Its 22 specialists will join the Ipsos Healthcare Insights team and Frank Ma, CEO and founder of Focus RX Research, will lead the new team.
Copyright (c) 2023 CercleFinance.com. All rights reserved.